Slow responses to standard dose rituximab in immune thrombocytopenic purpura. Author reply

Yazar: Zaja, Francesco, Fanin, Renato
Baskı/Yayın Bilgisi 2009

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

Yazar: Volpetti, Stefano, Zaja, Francesco, Fanin, Renato
Baskı/Yayın Bilgisi 2014

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

Yazar: Lucchini, Elisa, Zaja, Francesco, Bussel, James
Yayımlandı Haematologica (2019)

Indolent B-Cell Lymphomas Associated with HCV Infection: Clinical and Virological Features and Role of Antiviral Therapy

Yazar: Arcaini, Luca, Merli, Michele, Volpetti, Stefano, Rattotti, Sara, Gotti, Manuel, Zaja, Francesco
Baskı/Yayın Bilgisi 2012

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

Yazar: Golay, Josée, Semenzato, Gianpietro, Rambaldi, Alessandro, Foà, Robin, Gaidano, Gianluca, Gamba, Enrica, Pane, Fabrizio, Pinto, Antonello, Specchia, Giorgina, Zaja, Francesco, Regazzi, Mario
Baskı/Yayın Bilgisi 2013

Case Report: Cardiac Involvement by Lymphoma: Rare but Heterogeneous Condition With Challenging Behaviors

Yazar: Lucchini, Elisa, Merlo, Marco, Ballerini, Mario, Porcari, Aldostefano, Sinagra, Gianfranco, Pagnan, Lorenzo, Rensi, Marco, Romano, Andrea, Bussani, Rossana, Ballotta, Laura, Zaja, Francesco
Yayımlandı Front Oncol (2021)

Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic

Yazar: Rodeghiero, Francesco, Cantoni, Silvia, Carli, Giuseppe, Carpenedo, Monica, Carrai, Valentina, Chiurazzi, Federico, De Stefano, Valerio, Santoro, Cristina, Siragusa, Sergio, Zaja, Francesco, Vianelli, Nicola
Yayımlandı Mediterr J Hematol Infect Dis (2021)

Immune checkpoint inhibitors in combination with radiotherapy as salvage treatment for relapsed/refractory classical Hodgkin lymphoma: A retrospective analysis in 12 patients

Yazar: Lucchini, Elisa, Rusconi, Chiara, Levis, Mario, Ricci, Francesca, Santoro, Armando, Ricardi, Umberto, Volpetti, Stefano, Matrone, Fabio, di Russo, Anna, Caizzi, Manuela, Schiattarella, Anna, Zaja, Francesco
Yayımlandı Hematol Rep (2021)

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory...

Yazar: Balzarotti, Monica, Magagnoli, Massimo, Canales, Miguel Ángel, Corradini, Paolo, Grande, Carlos, Sancho, Juan-Manuel, Zaja, Francesco, Quinson, Anne-Marie, Belsack, Valérie, Maier, Daniela, Carlo-Stella, Carmelo
Yayımlandı Invest New Drugs (2021)

Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination

Yazar: Ferreri, Andrés J. M., Licata, Giada, Foppoli, Marco, Corazzelli, Gaetano, Zucca, Emanuele, Stelitano, Caterina, Zaja, Francesco, Fava, Sergio, Paolini, Rossella, Franzin, Alberto, Politi, Letterio S., Ponzoni, Maurilio, Reni, Michele
Baskı/Yayın Bilgisi 2011

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years

Yazar: Vianelli, Nicola, Palandri, Francesca, Polverelli, Nicola, Stasi, Roberto, Joelsson, Joel, Johansson, Eva, Ruggeri, Marco, Zaja, Francesco, Cantoni, Silvia, Catucci, Angelo Emanuele, Candoni, Anna, Morra, Enrica, Björkholm, Magnus, Baccarani, Michele, Rodeghiero, Francesco
Baskı/Yayın Bilgisi 2013

Brentuximab vedotin in relapsed/refractory Hodgkin’s lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

Yazar: Zinzani, Pier Luigi, Viviani, Simonetta, Anastasia, Antonella, Vitolo, Umberto, Luminari, Stefano, Zaja, Francesco, Corradini, Paolo, Spina, Michele, Brusamolino, Ercole, Gianni, Alessandro M., Santoro, Armando, Botto, Barbara, Derenzini, Enrico, Pellegrini, Cinzia, Argnani, Lisa
Baskı/Yayın Bilgisi 2013

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study

Yazar: Fattizzo, Bruno, Michel, Marc, Zaninoni, Anna, Giannotta, Juri A., Guillet, Stephanie, Frederiksen, Henrik, Vos, Josephine M.I., Mauro, Francesca R., Jilma, Bernd, Patriarca, Andrea, Zaja, Francesco, Hill, Anita, Berentsen, Sigbjørn, Barcellini, Wilma
Yayımlandı Haematologica (2020)

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials

Yazar: Bussel, James, Arnold, Donald M., Grossbard, Elliot, Mayer, Jiří, Treliński, Jacek, Homenda, Wojciech, Hellmann, Andrzej, Windyga, Jerzy, Sivcheva, Liliya, Khalafallah, Alhossain A., Zaja, Francesco, Cooper, Nichola, Markovtsov, Vadim, Zayed, Hany, Duliege, Anne‐Marie
Yayımlandı Am J Hematol (2018)

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines

Yazar: D’Agaro, Tiziana, Zucchetto, Antonella, Vit, Filippo, Bittolo, Tamara, Tissino, Erika, Rossi, Francesca Maria, Degan, Massimo, Zaja, Francesco, Bulian, Pietro, Bo, Michele Dal, Ferrero, Simone, Ladetto, Marco, Zamò, Alberto, Gattei, Valter, Bomben, Riccardo
Yayımlandı Haematologica (2019)

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum

Yazar: Ferreri, Andrés J. M., Sassone, Marianna, Miserocchi, Elisabetta, Govi, Silvia, Cecchetti, Caterina, Corti, Matteo E., Mappa, Silvia, Arcaini, Luca, Zaja, Francesco, Todeschini, Giuseppe, Mannina, Donato, Calimeri, Teresa, Perrone, Salvatore, Ponzoni, Maurilio, Modorati, Giulio
Yayımlandı Blood Adv (2020)

The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells

Yazar: Dal Bo, Michele, D'Agaro, Tiziana, Gobessi, Stefania, Zucchetto, Antonella, Dereani, Sara, Rossi, Davide, Zaja, Francesco, Pozzato, Gabriele, Di Raimondo, Francesco, Gaidano, Gianluca, Laurenti, Luca, Del Poeta, Giovanni, Efremov, Dimitar G., Gattei, Valter, Bomben, Riccardo
Yayımlandı Oncotarget (2015)

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers

Yazar: Zaja, Francesco, De Luca, Stefano, Vitolo, Umberto, Orsucci, Lorella, Levis, Alessandro, Salvi, Flavia, Rusconi, Chiara, Ravelli, Erika, Tucci, Alessandra, Bottelli, Chiara, Balzarotti, Monica, Brusamolino, Ercole, Bonfichi, Maurizio, Pileri, Stefano A., Sabattini, Elena, Volpetti, Stefano, Monagheddu, Chiara, Vacca, Angelo, Ria, Roberto, Fanin, Renato
Baskı/Yayın Bilgisi 2012

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

Yazar: Staber, Philipp B., Herling, Marco, Bellido, Mar, Jacobsen, Eric D., Davids, Matthew S., Kadia, Tapan Mahendra, Shustov, Andrei, Tournilhac, Olivier, Bachy, Emmanuel, Zaja, Francesco, Porkka, Kimmo, Hoermann, Gregor, Simonitsch-Klupp, Ingrid, Haferlach, Claudia, Kubicek, Stefan, Mayerhoefer, Marius E., Hopfinger, Georg, Jaeger, Ulrich, Dearden, Claire
Yayımlandı Blood (2019)

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical a...

Yazar: Pozzo, Federico, Dal Bo, Michele, Peragine, Nadia, Bomben, Riccardo, Zucchetto, Antonella, Rossi, Francesca Maria, Degan, Massimo, Rossi, Davide, Chiarenza, Annalisa, Grossi, Alberto, Di Raimondo, Francesco, Zaja, Francesco, Pozzato, Gabriele, Secchiero, Paola, Gaidano, Gianluca, Del Poeta, Giovanni, Zauli, Giorgio, Foà, Robin, Guarini, Anna, Gattei, Valter
Yayımlandı J Hematol Oncol (2013)